Incyte Corp (INCY)
The Company is a drug discovery and development company focused on developing proprietary small molecule drugs to treat serious unmet medical needs.
Recs
SorrySam
(< 20)
Submitted: 11/5/2009 5:19:12 PM :
Start Price:
$6.87
INCY Score:
+19.01
drug likely to get approved even though its for a small condition.
Recs
bklynmp3j
(94.23)
Submitted: 8/25/2009 12:23:31 AM :
Start Price:
$6.15
INCY Score:
+29.89
insider buying
Recs
karthi2209
(70.26)
Submitted: 6/21/2009 8:54:53 PM :
Start Price:
$3.27
INCY Score:
+135.76
the company has been beaten down in the recession. it has a few good drugs in the pipe line and can be a potential 15 $ stock in a year or 2.
Recs
PhillyDan
(89.85)
Submitted: 6/16/2009 6:42:56 PM :
Start Price:
$3.19
INCY Score:
+142.15
As someone who suffers from psoriasis, there are not a lot of effective treatments on the market. Incyte's drug candidate for Psoriasis will do very well once it has FDA approval and if they also get approval for a topical solution to treat mild to moderate psoriasis this could be a home run revenue producer.
Recs
slimjim2005007
(< 20)
Submitted: 6/9/2009 11:04:40 PM :
Start Price:
$3.42
INCY Score:
+128.39
INCY DIABETIC DRUG COULD BE WORTH A BILLION DOLLARS
THEY ALSO HAVE A FEW OTHER DRUGS COMING UP WORTH THE SAME AMOUNT, A BILLION DOLLAR COMPANY IN THE WORKS.
Recs
brianmccurdy
(86.14)
Submitted: 6/9/2009 1:44:31 PM :
Start Price:
$3.49
INCY Score:
+123.38
Part of a screen looking for newly coined 5-star stocks that have moved up from 2 or 3-stars. Total speculation.
Recs
gridster
(< 20)
Submitted: 4/10/2008 1:35:56 PM :
Start Price:
$10.98
INCY Score:
-6.89
Incy is on the threshhold of new and innovative drug therapy for various cancers. Their genetic research is fantastic and will prove to be very rewarding over the next year or two
Recs
ScienceInvestor
(79.59)
Submitted: 3/21/2008 8:59:59 PM :
Start Price:
$9.54
INCY Score:
+2.71
Great product line for the speculative investor. The company carries a lot of debt that will be offset with an approved drug candidate. The growth from the potential product pipeline is the attractive aspect of this security. I don't have a crystal ball, but assuming the big pipeline drugs prove positive this is a high flyer and I'm putting some of my chips on INCY and their product pipeline....
Recs
PPT1
(93.82)
Submitted: 2/13/2008 11:11:11 AM :
Start Price:
$12.05
INCY Score:
-14.49
Innovative drug pipeline for common diseases such as Diabetes
Recs
rustynail007
(82.36)
Submitted: 12/31/2007 2:05:41 PM :
Start Price:
$10.13
INCY Score:
+5.17
FOR A SMALL BIO COMP, IT HAS SOME GOOD LOOKING DRUGS THAT COULD BE COMING TO THE MARKET IN THE NEXT 2 TH 4 YEARS !!!!!! ALL WAYS LOOKING FOR GOOD SMALL BIO COMP THAT HAVE A GOOD PRODUCR PIPE LINE.
Recs
mroth5745
(< 20)
Submitted: 12/18/2007 2:31:00 PM :
Start Price:
$10.64
INCY Score:
+0.33
In the pipeline with good trials
Recs
BetterMoney77
(24.43)
Submitted: 12/10/2007 6:19:18 PM :
Start Price:
$9.90
INCY Score:
+9.30
Nice chart pattern, starting to get bullish on the longer term chart. Has to break 10.00, it's at 9.87 now.
Recs
morningstarboy
(< 20)
Submitted: 12/5/2007 1:03:03 PM :
Start Price:
$9.31
INCY Score:
-12.81
As of close of business on 12/04/2007, this was a 1-star Morningstar stock that was trading at more than double it's Morningstar fair value.
Recs
4thRockFool
(26.11)
Submitted: 10/21/2007 7:31:05 AM :
Start Price:
$8.15
INCY Score:
+25.83
Super management team with proven track record. Multiple promising drug candidates in pipeline.
Recs
ritr54
(57.34)
Submitted: 10/4/2007 3:24:53 PM :
Start Price:
$7.54
INCY Score:
+36.71
Loads of insider buying, lots of recent good news -a catalyst stock
Recs
kenparent
(< 20)
Submitted: 10/2/2007 8:11:23 AM :
Start Price:
$7.18
INCY Score:
+42.60
deep pipe,good crew
Recs
Recs
TheGrtGdOM
(61.29)
Submitted: 8/11/2007 7:48:45 PM :
Start Price:
$5.50
INCY Score:
+73.81
Mainly on the recommendaion of a freind in the Pharma industry who is overall down on the industry's prospects but who says that this company's prospects are exciting. No insider information implied, just based on his public knowledge assessments.
Besides that there is the contrarian in me. Biotech overall is way out of favor right now yet Big Pharma is increasingly wanting to let the small firms do the creative work and then either buy the product rights or the company when they hit one. (They are also farming out the testing to companies like Covance.) I like buying when others have been selling.
Recs
stenoman
(< 20)
Submitted: 8/6/2007 5:08:50 PM :
Start Price:
$5.34
INCY Score:
+78.08
No idea just hoping it will.
Recs
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 28 1 2 Next »